Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Pharma Gathers to Discuss 'One of the Most Fundamental Changes in the Pharma Industry Today' Representatives from every global pharmaceutical company including UCB, Novartis, Pfizer, Merck, Bayer and Grunenthal will gather at an annual industry summit to determine the future of patient-centric healthcare, which some believe to be the most fundamental change to the system in decades.
Billions of dollars are now being invested in patient-centric healthcare within the pharmaceutical industry and wider healthcare landscape, providing a clear demonstration that the term is moving beyond simply the latest marketing 'buzzword' to become a fundamental pillar in the future of medical treatment.
Speaking to eyeforpharma ahead of the annual 3-day summit where industry leaders will meet to set the benchmark of the future of patient value, Lode Dewulf, Chief Patient Officer at UCB described patient-centric healthcare as "one of the most fundamental changes in the pharma industry today and in the future".
Over 1000 senior pharmaceutical and healthcare executives will attend the summit; which will also be looking at building value for your customer in three key areas. Value Partnerships, Sales Excellence and Multichannel Marketing, are today almost unrecognizable compared to industry standards as little as two years ago, and are set to continue to evolve at a exponential rate in the coming years as the terms 'patient' and 'value' seep in to every facet of industry practice.
"The movement towards a more business and customer focused approach within pharma continues and I'll be looking to network with, and hear from, like-minded individuals who are determined to accelerate their organisation's progress. I hope to take away some key actions that will enable us to accelerate and improve our overall implementation of an innovative new approach to our business" said Allan Mackintosh of Grunenthal.
eyeforpharma Barcelona will be taking place 18-20th March, 2014. For more information on the summit, to see who else will be in attendance, or to find out how this year's agenda will influence your future business practices visit the official website.
Event: 12th Annual eyeforpharma Barcelona 2014
Dates: 18th - 20th March 2014
Location: CCIB, Barcelona
For more information contact:
Article adapted by Medical News Today from original press release. Source:
Please use one of the following formats to cite this article in your essay, paper or report:
EyeforPharma. "One of the most fundamental changes in the pharma industry today to be discussed at Eyeforpharma Barcelona 2014, March, 18-20." Medical News Today. MediLexicon, Intl., 25 Sep. 2013. Web.
6 Dec. 2013. <http://www.medicalnewstoday.com/releases/266595>
EyeforPharma. (2013, September 25). "One of the most fundamental changes in the pharma industry today to be discussed at Eyeforpharma Barcelona 2014, March, 18-20." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/266595.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.